← All companies

VRAX

Virax Biolabs Group Limited

VRAX Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗

$2.94

+0.14 +5.00%

Key statistics

from XBRL data in SEC filings

Market cap

$1.70M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$2.50 – $21.75

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 31, 2026 6-K Jul 16, 2026 6-K Jul 10, 2026 6-K Jul 9, 2026 20-F Jul 6, 2026 6-K Jun 24, 2026 6-K Jun 12, 2026 6-K May 26, 2026 6-K May 22, 2026 6-K Apr 14, 2026 6-K Apr 10, 2026 6-K Mar 18, 2026 6-K Jan 30, 2026 6-K Dec 4, 2025 6-K Dec 2, 2025 6-K Jul 30, 2025 20-F Jul 2, 2025 6-K Jun 13, 2025 6-K Mar 18, 2025 6-K Mar 13, 2025 6-K Mar 5, 2025 6-K Feb 25, 2025 6-K Dec 23, 2024 6-K Dec 17, 2024 6-K Dec 10, 2024 6-K Nov 20, 2024 6-K Oct 31, 2024 6-K Oct 23, 2024 6-K Sep 30, 2024 6-K Aug 23, 2024 20-F Aug 20, 2024 6-K Jun 11, 2024 6-K Apr 25, 2024 6-K Apr 16, 2024 6-K Mar 15, 2024 6-K Jan 22, 2024 6-K Jan 12, 2024 6-K Dec 21, 2023 6-K Dec 20, 2023 6-K Dec 18, 2023